VC-backed Galecto raises $85m for IPO
Galecto, a Danish developer of treatments for fibrotic and related diseases, including cancer, has raised about $85 million for its IPO after pricing its over 5.6 million shares at $15 per share.
Galecto, a Danish developer of treatments for fibrotic and related diseases, including cancer, has raised about $85 million for its IPO after pricing its over 5.6 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination